Ventria Bioscience Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

Ventria Bioscience General Information

Description

Developer of pharmaceutical medicines intended to improve human longevity and quality of life. The company's medicines focus on facilitating the production of pure, recombinant proteins derived from known, safe sources, with proven benefits, enabling medical practitioners to treat patients with inflammatory, infectious, and gastrointestinal diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 330
  • Aurora, CO 80045
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 330
  • Aurora, CO 80045
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ventria Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 01-Aug-2023 Completed Generating Revenue
9. Debt - PPP 08-Apr-2020 Completed Generating Revenue
8. Grant 01-Jan-2017 Completed Generating Revenue
7. Later Stage VC Completed Generating Revenue
6. Grant 01-Jan-2014 Completed Generating Revenue
5. Grant 04-Sep-2012 Completed Generating Revenue
4. Grant 01-Jan-2010 Completed Generating Revenue
3. Grant 12-Mar-2007 Completed Generating Revenue
2. Grant 01-Jan-2007 $100K Completed Generating Revenue
1. Grant 01-Jan-2006 $503K Completed Generating Revenue
To view Ventria Bioscience’s complete valuation and funding history, request access »

Ventria Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ventria Bioscience Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gates Foundation Not-For-Profit Venture Capital
Kansas Bioscience Authority Government
National Institute Of Allergy and Infectious Diseases Government
National Institute of Alcohol Abuse and Alcoholism Government
National Institute on Aging Government
You’re viewing 5 of 7 investors. Get the full list »

Ventria Bioscience FAQs

  • When was Ventria Bioscience founded?

    Ventria Bioscience was founded in 1993.

  • Where is Ventria Bioscience headquartered?

    Ventria Bioscience is headquartered in Aurora, CO.

  • What is the size of Ventria Bioscience?

    Ventria Bioscience has 33 total employees.

  • What industry is Ventria Bioscience in?

    Ventria Bioscience’s primary industry is Discovery Tools (Healthcare).

  • Is Ventria Bioscience a private or public company?

    Ventria Bioscience is a Private company.

  • What is Ventria Bioscience’s current revenue?

    The current revenue for Ventria Bioscience is .

  • Who are Ventria Bioscience’s investors?

    Gates Foundation, Kansas Bioscience Authority, National Institute Of Allergy and Infectious Diseases, National Institute of Alcohol Abuse and Alcoholism, and National Institute on Aging are 5 of 7 investors who have invested in Ventria Bioscience.

  • When was Ventria Bioscience acquired?

    Ventria Bioscience was acquired on 01-Aug-2023.

  • Who acquired Ventria Bioscience?

    Ventria Bioscience was acquired by ExpressTec (Food Products).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process